Strata Oncology Presents Data at ASCO 2021 Showing Comprehensive Genomic and Transcriptomic Profiling Predicts Pan-Tumor Benefit of Pembrolizumab
ANN ARBOR, Mich., June 04, 2021 /PRNewswire/ -- Strata Oncology®, Inc., a precision oncology company advancing molecular indications for cancer therapies,...